Cargando…

The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study

BACKGROUND/AIMS: Anti-phospholipase A2 receptor (PLA2R) autoantibody is the main biomarker of idiopathic membranous nephropathy (IMN). We aimed to find a new cutoff value of anti-PLA2R for patients with IMN and to explore the relevance between this antibody and baseline clinical parameters. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chaofan, Li, Ping, Guo, Wenkai, Chen, Lei, Li, Jiatong, Wang, Rong, Chen, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747929/ https://www.ncbi.nlm.nih.gov/pubmed/32972118 http://dx.doi.org/10.3904/kjim.2020.366

Ejemplares similares

Retrospective study: clinicopathological features and prognosis of idiopathic membranous nephropathy with seronegative anti-phospholipase A2 receptor antibody
por: Guo, Wenkai, et al.
Publicado: (2020)

Clinical and pathological features of idiopathic membranous nephropathy with focal segmental sclerosis
por: Li, Jiatong, et al.
Publicado: (2019)

The cutoff value and prognosis of anti-PLA2R antibody for idiopathic membranous nephropathy: a single-center retrospective study in China
por: Guo, Hongxia, et al.
Publicado: (2023)

Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage
por: Sun, Mengyao, et al.
Publicado: (2023)

Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy
por: Xu, Ning-Xin, et al.
Publicado: (2017)

Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study
por: Zhao, Yuchao, et al.
Publicado: (2022)

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy
por: Jullien, Perrine, et al.
Publicado: (2017)

Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China
por: Guo, Naifeng, et al.
Publicado: (2019)

Current concepts on anti-Phospholipase A2 receptor antibody in Idiopathic membranous nephropathy
por: Ardalan, Mohammad Reza
Publicado: (2013)

Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: New concepts
por: Ardalan, Mohammad-Reza, et al.
Publicado: (2013)

Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan
por: Liu, Yu-Huei, et al.
Publicado: (2010)

Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody
por: Cui, Hao-yuan, et al.
Publicado: (2021)

Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study
por: Xie, Zhiyong, et al.
Publicado: (2020)

Anti-Phospholipase A2 Receptor Antibody Expression at Different Stages of Idiopathic Membranous Nephropathy
por: Fu, Keying, et al.
Publicado: (2022)

Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2017)

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients
por: Wang, Bihua, et al.
Publicado: (2022)

Advances of the experimental models of idiopathic membranous nephropathy
por: Jiang, Han Xue, et al.
Publicado: (2020)

Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy
por: Dong, Lei, et al.
Publicado: (2022)

Clinical and pathological features of anti-glomerular basement membrane disease associated with membranous nephropathy: an observational study
por: Zhang, Shasha, et al.
Publicado: (2022)

Receptor antibody time‐resolved A2 phospholipase bead immunochromatography and its application in idiopathic membranous nephropathy
por: Huang, Biao, et al.
Publicado: (2020)

Correction: Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients
por: Wang, Bihua, et al.
Publicado: (2022)

Phospholipase‐A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy
por: Xiao, Chunying, et al.
Publicado: (2020)

Association of gut microbiota with idiopathic membranous nephropathy
por: Li, Mengfei, et al.
Publicado: (2022)

Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy
por: Dong, Hong-rui, et al.
Publicado: (2016)

Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy
por: Shang, Shun-Lai, et al.
Publicado: (2018)

Optimal Cutoffs for the Diagnosis of Sarcopenia in Older Chinese Adults
por: Ge, Sheng, et al.
Publicado: (2022)

Analysis of predictive factors for immunosuppressive response in anti-phospholipase A2 receptor antibody positive membranous nephropathy
por: Li, Chao, et al.
Publicado: (2018)

Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study
por: Jiang, Zhenbin, et al.
Publicado: (2021)

Role of Anti-Phospholipase A(2) Receptor Antibodies in the Differential Diagnosis of Diabetic and Membranous Nephropathy
por: Pocivalnik, Mirjam, et al.
Publicado: (2013)

Anti-phospholipase A2 receptor antibodies in membranous nephropathy
por: Lee, Sangho
Publicado: (2018)

Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy
por: Zhang, Qiuhua, et al.
Publicado: (2017)

Helper T Cells in Idiopathic Membranous Nephropathy
por: Zhao, Qihan, et al.
Publicado: (2021)

Assessment of the optimal cutoff value of fasting plasma glucose to establish diagnosis of gestational diabetes mellitus in Chinese women
por: Yan, Bing, et al.
Publicado: (2019)

Optimal cutoffs of growth discordance for the risk of preeclampsia in twin pregnancies: A single-center retrospective cohort study
por: Zhu, Jie, et al.
Publicado: (2023)

Identifying the optimal cutoff point of Ki-67 in breast cancer: a single-center experience
por: Li, Wang, et al.
Publicado: (2023)

Correlation of Body Mass Index with Clinicopathologic Parameters in Patients with Idiopathic Membranous Nephropathy
por: Chen, Xing, et al.
Publicado: (2022)

Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2019)

The prognostic value of phospholipase A2 receptor autoantibodies on spontaneous remission for patients with idiopathic membranous nephropathy: A meta-analysis
por: Wu, Wenli, et al.
Publicado: (2018)

Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience
por: Porcelli, Brunetta, et al.
Publicado: (2020)

Associations between m-type phospholipase A2 receptor,human leukocyte antigen gene polymorphisms and idiopathic membranous nephropathy
por: Liu, Xiaogang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m58r021j7jqnqcqpt2urcot3l0